Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Sensors (Basel, Switzerland)|October 29, 2025
Robotic Ankle Assessment Post-Stroke: Reliability, Comparison to Therapists, and Benchmark Dataset DevelopmentChristopher A Johnson, Andria J Farrens, Piyashi Biswas, et al.Nutrients|October 16, 2025
Adhering to Healthy Dietary Patterns Prevents Cognitive Decline of Older Adults with Sarcopenia: The Mr. OS and Ms. OS StudyYichen Jin, Gianna Lai, Shuyi Li, et al.BMC Neurology|June 13, 2024
A single-center, assessor-blinded, randomized controlled clinical trial to test the safety and efficacy of a novel brain-computer interface controlled functional electrical stimulation (BCI-FES) intervention for gait rehabilitation in the chronic stroke populationPiyashi Biswas, Lucy Dodakian, Po T Wang, et al.The Plant Journal : for Cell and Molecular Biology|June 20, 2014
Roles of small RNAs in soybean defense against Phytophthora sojae infectionJames Wong, Lei Gao, Yang Yang, et al.Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Discovery of a new class of glucosylceramide synthase inhibitorsElena Koltun, Steven Richards, Vicky Chan, et al.Journal of Medicinal Chemistry|April 14, 2012
Discovery and characterization of an inhibitor of glucosylceramide synthaseSteven Richards, Christopher J Larson, Elena S Koltun, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2012
The design, synthesis, and biological evaluation of PIM kinase inhibitorsAmy Lew Tsuhako, David S Brown, Elena S Koltun, et al.Blood Advances|February 24, 2022
Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccinationAgnes Y Y Lee, Muntadhar Al Moosawi, Erica A Peterson, et al.Bioorganic & Medicinal Chemistry Letters|May 8, 2012
Discovery of XL413, a potent and selective CDC7 inhibitorElena S Koltun, Amy Lew Tsuhako, David S Brown, et al.Bioorganic & Medicinal Chemistry Letters|November 7, 2012
SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitorsTimothy Forsyth, Patrick C Kearney, Byung Gyu Kim, et al.Pageof 7